Page 9 - 2019_07 resto del Mondo-web

haematologica Journal of the Ferrata Storti Foundation
e293 Persistence with generic imatinib for chronic myeloid leukemia: a matched cohort study Adi J. Klil-Drori et al.
http://www.haematologica.org/content/104/7/e293
e296 miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia Estrella Gonzales-Aloy et al.
http://www.haematologica.org/content/104/7/e296
e300 Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia
Laurence C. Cheung et al.
http://www.haematologica.org/content/104/7/e300
e304 Allogeneic transplantation in high-risk chronic lymphocytic leukemia: a single-center, intent-to-treat analysis Almuth Hoffmann et al.
http://www.haematologica.org/content/104/7/e304
e307 The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents Chiara Tarantelli et al.
http://www.haematologica.org/content/104/7/e307
e310 PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma Barbara Muz et al.
http://www.haematologica.org/content/104/7/e307
e314 A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation
Jed Paul et al. http://www.haematologica.org/content/104/7/e314
Case Reports
Case Reports are available online only at www.haematologica.org/content/104/7.toc
e318 A novel germline SAMD9L mutation in a family with ataxia-pancytopenia syndrome and pediatric acute lymphoblastic leukemia Jesse J.C. Cheah et al.
http://www.haematologica.org/content/104/7/e318
e322 Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression Francesca Todaro et al.
http://www.haematologica.org/content/104/7/e322
e326 Branched clonal evolution: nodal follicular lymphoma and primary diffuse large B-cell lymphoma of the central nervous system Gilberto I. Barranco et al.
http://www.haematologica.org/content/104/7/e326
Comments
Comments are available online only at www.haematologica.org/content/104/7.toc
e330 The tolerability issue of generic imatinib in patients with chronic myeloid leukemia. (Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293)
Ahmet Emre Eskazan and Teoman Soysal
http://www.haematologica.org/content/104/7/e330
Haematologica 2019; vol. 104 no. 7 - July 2019 http://www.haematologica.org/